Literature DB >> 23602541

Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction.

Asmin Tulpule1, James M Kelley, M William Lensch, Jade McPherson, In Hyun Park, Odelya Hartung, Tomoka Nakamura, Thorsten M Schlaeger, Akiko Shimamura, George Q Daley.   

Abstract

Shwachman-Diamond syndrome (SDS), a rare autosomal-recessive disorder characterized by exocrine pancreatic insufficiency and hematopoietic dysfunction, is caused by mutations in the Shwachman-Bodian-Diamond syndrome (SBDS) gene. We created human pluripotent stem cell models of SDS through knockdown of SBDS in human embryonic stem cells (hESCs) and generation of induced pluripotent stem cell (iPSC) lines from two patients with SDS. SBDS-deficient hESCs and iPSCs manifest deficits in exocrine pancreatic and hematopoietic differentiation in vitro, enhanced apoptosis, and elevated protease levels in culture supernatants, which could be reversed by restoring SBDS protein expression through transgene rescue or by supplementing culture media with protease inhibitors. Protease-mediated autodigestion provides a mechanistic link between the pancreatic and hematopoietic phenotypes in SDS, highlighting the utility of hESCs and iPSCs in obtaining novel insights into human disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602541      PMCID: PMC3755012          DOI: 10.1016/j.stem.2013.04.002

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  33 in total

1.  Novel SBDS mutations caused by gene conversion in Japanese patients with Shwachman-Diamond syndrome.

Authors:  Eiji Nakashima; Akihiko Mabuchi; Yoshio Makita; Mitsuo Masuno; Hirofumi Ohashi; Gen Nishimura; Shiro Ikegawa
Journal:  Hum Genet       Date:  2004-01-29       Impact factor: 4.132

2.  Loss of the mouse ortholog of the shwachman-diamond syndrome gene (Sbds) results in early embryonic lethality.

Authors:  Siyi Zhang; Mingjun Shi; Chi-Chung Hui; Johanna M Rommens
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations.

Authors:  E Tsangaris; R Klaassen; C V Fernandez; R Yanofsky; E Shereck; J Champagne; M Silva; J H Lipton; J Brossard; B Michon; S Abish; M Steele; K Ali; N Dower; U Athale; L Jardine; J P Hand; I Odame; P Canning; C Allen; M Carcao; J Beyene; C M Roifman; Y Dror
Journal:  J Med Genet       Date:  2011-06-09       Impact factor: 6.318

4.  The Shwachman-Diamond SBDS protein localizes to the nucleolus.

Authors:  Karyn M Austin; Rebecca J Leary; Akiko Shimamura
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

5.  Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Authors:  Jean Donadieu; Thierry Leblanc; Brigitte Bader Meunier; Mohamed Barkaoui; Odile Fenneteau; Yves Bertrand; Micheline Maier-Redelsperger; Marguerite Micheau; Jean Louis Stephan; Noel Phillipe; Pierre Bordigoni; Annie Babin-Boilletot; Philippe Bensaid; Anne Marie Manel; Etienne Vilmer; Isabelle Thuret; Stephane Blanche; Eliane Gluckman; Alain Fischer; Françoise Mechinaud; Bertrand Joly; Thierry Lamy; Olivier Hermine; Bruno Cassinat; Christine Bellanné-Chantelot; Christine Chomienne
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

6.  Mutations in the SBDS gene in acquired aplastic anemia.

Authors:  Rodrigo T Calado; Solomon A Graf; Keisha L Wilkerson; Sachiko Kajigaya; Philip J Ancliff; Yigal Dror; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

7.  The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome.

Authors:  A Minelli; E Maserati; E Nicolis; M Zecca; L Sainati; D Longoni; F Lo Curto; G Menna; F Poli; E De Paoli; M Cipolli; F Locatelli; F Pasquali; C Danesino
Journal:  Leukemia       Date:  2009-01-15       Impact factor: 11.528

8.  Shwachman-Diamond syndrome is associated with low-turnover osteoporosis.

Authors:  Sanna Toiviainen-Salo; Mervi K Mäyränpää; Peter R Durie; Nicole Richards; Marc Grynpas; Lynda Ellis; Shiro Ikegawa; William G Cole; Johanna Rommens; Eino Marttinen; Erkki Savilahti; Outi Mäkitie
Journal:  Bone       Date:  2007-09-05       Impact factor: 4.398

9.  Impaired ribosomal subunit association in Shwachman-Diamond syndrome.

Authors:  Nicholas Burwick; Scott A Coats; Tomoka Nakamura; Akiko Shimamura
Journal:  Blood       Date:  2012-10-31       Impact factor: 22.113

10.  Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.

Authors:  Karyn M Austin; Mohan L Gupta; Scott A Coats; Asmin Tulpule; Gustavo Mostoslavsky; Alejandro B Balazs; Richard C Mulligan; George Daley; David Pellman; Akiko Shimamura
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more
  37 in total

1.  Generation of CD44 gene-deficient mouse derived induced pluripotent stem cells: CD44 gene-deficient iPSCs.

Authors:  Zhenwei Song; Qianqian Ji; Haijing Zhao; Yu Nie; Zuyong He; Yaosheng Chen; Peiqing Cong
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-21       Impact factor: 2.416

2.  Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes.

Authors:  Noemi A Zambetti; Eric M J Bindels; Paulina M H Van Strien; Marijke G Valkhof; Maria N Adisty; Remco M Hoogenboezem; Mathijs A Sanders; Johanna M Rommens; Ivo P Touw; Marc H G P Raaijmakers
Journal:  Haematologica       Date:  2015-07-16       Impact factor: 9.941

Review 3.  Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.

Authors:  Ryan C Smith; Viviane Tabar
Journal:  Cell Stem Cell       Date:  2018-12-20       Impact factor: 24.633

Review 4.  Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering.

Authors:  Moonjung Jung; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2015-10-05       Impact factor: 11.454

Review 5.  Modeling rare diseases with induced pluripotent stem cell technology.

Authors:  Ruthellen H Anderson; Kevin R Francis
Journal:  Mol Cell Probes       Date:  2018-01-05       Impact factor: 2.365

6.  Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.

Authors:  Melisa Ruiz-Gutierrez; Özge Vargel Bölükbaşı; Gabriela Alexe; Adriana G Kotini; Kaitlyn Ballotti; Cailin E Joyce; David W Russell; Kimberly Stegmaier; Kasiani Myers; Carl D Novina; Eirini P Papapetrou; Akiko Shimamura
Journal:  JCI Insight       Date:  2019-04-30

Review 7.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

Review 8.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 9.  [Induced pluripotent stem cells. A new resource in modern medicine].

Authors:  S Liebau; M Stockmann; A Illing; T Seufferlein; A Kleger
Journal:  Internist (Berl)       Date:  2014-04       Impact factor: 0.743

Review 10.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.